Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-25

FDA Approved: ENTECAVIR — Original Application (EPIC PHARMA, LLC)

View source ↗

Summary

FDA approves EPIC PHARMA, LLC's original application for entecavir (ENTECAVIR), a generic antiviral for chronic hepatitis B infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENTECAVIR (ENTECAVIR)

Snippet

ORIG AP for ENTECAVIR (ENTECAVIR)